Researchers have identified a receptor protein known as CHRM1 as a key player in prostate cancer cells’ resistance to docetaxel, a commonly used chemotherapy drug to treat advanced cancer that has spread beyond the prostate.
Top Insomnia Treatments Offer Little Relief for Dialysis Patients
Two common treatments for insomnia flopped for patients undergoing hemodialysis, according to the SLEEP-HD trial. After 6 weeks of treatment, people who underwent cognitive behavioral